TNF and myeloid sarcoma: As shown in Fig. 10A, nicotine supplementation decreased TNF-α release from NCM-stimulated microglia and the nicotine effect was dose-dependent, confirming that nicotine has an anti-inflammatory function under MS/EAE relevant conditions.